Boldabol 200

British Dragon
💉
Boldabol 200 British Dragon
Boldenone Undecylenate 200 mg/ml · Low Aromatization · Lean Mass
🧬
Class
Boldenone Undecylenate
Injectable AAS (EQ)
⏱️
Half-Life
~14 days
Undecylenate ester
Aromatization
Low
~50% of testosterone
🎯
User Level
Intermediate
14–20 week cycles

Typical Dose
400–600 mg
per week
Frequency
2×/week
e.g. Mon + Thu
Cycle Length
14–20 wks
long ester — needs time
Lab Tested
$50.00
$50.00
In Stock
Manufacturer British Dragon
Brand Equipoise, EQ
Substance Boldenone Undecylenate
Concentration 200 mg/ml
Pack Size 10 ml
Shipping

Boldabol 200 British Dragon — Overview

Boldabol 200 British Dragon is boldenone undecylenate dosed at 200 mg/ml in a 10 ml vial — 2,000 mg per vial. Boldenone is a modified testosterone derivative with a distinct pharmacological profile: lower aromatization, stronger vascularization, a pronounced appetite-stimulating effect, and a notably slower onset than most injectable AAS. It is primarily used in lean mass and body recomposition cycles where the goal is quality muscle accumulation with controlled water retention — rather than the rapid bulk and fluid gains associated with high-dose testosterone or nandrolone.

This page covers boldenone's mechanism, how it differs from other BD injectable compounds, standard dosing and cycle structure, combination protocols, side effect management with specific attention to hematocrit, and post-cycle recovery timing.

Boldenone Undecylenate Injectable AAS Low Aromatization Lean Mass Recomposition Intermediate

About the Compound: Boldenone Undecylenate

Boldenone undecylenate is a testosterone derivative with one structural modification — a double bond at the C1–C2 position. This change significantly reduces the compound's affinity for the aromatase enzyme, cutting estrogen conversion to approximately 50% of testosterone's rate. It also resists 5α-reduction to a potent DHT analog, which means boldenone's androgenic impact at tissues like the scalp and skin is lower than testosterone's.

The undecylenate ester gives boldenone an approximate half-life of 14 days — similar to testosterone enanthate — with 2×/week injections as the standard frequency. The compound is slow-building by nature: blood levels stabilize gradually over 4–6 weeks, and visible physical changes typically begin appearing at weeks 4–6. This pharmacokinetic profile is the reason boldenone cycles run 14–20 weeks rather than the 8–12 weeks common with faster compounds.

At 200 mg/ml, Boldabol 200 is the standard-concentration entry point into boldenone. Each milliliter delivers 200 mg — at 400 mg/week (the common starting dose), this means 1 ml per injection, twice weekly. One 10 ml vial covers exactly 5 weeks at this dose.

Active Substance
Boldenone Undecylenate
Concentration
200 mg/ml
Vial Volume
10 ml (2,000 mg total)
Half-Life
~14 days
Aromatization
Low (~50% of test)
Injection Volume
1 ml per pin at 400 mg/wk

What Boldabol 200 Does

Boldenone's effects are gradual and cumulative — the compound builds slowly and the gains it produces are correspondingly durable. Users running a full 16–20 week Boldabol cycle consistently report the following:

  • Lean, dry muscle accumulation — boldenone promotes nitrogen retention and protein synthesis through androgen receptor activation while contributing significantly less estrogen-driven water retention than testosterone at equivalent doses. Mass gained on a boldenone cycle tends to be more visible and more easily maintained post-cycle than testosterone-dominant bulk gains.
  • Pronounced vascularization — boldenone's EPO-stimulating effect raises red blood cell mass, which combined with lower subcutaneous water retention, dramatically increases visible vascularity. This is one of boldenone's most consistently reported subjective effects.
  • Appetite stimulation — a characteristic effect of boldenone not shared by most other AAS at comparable doses. Users report a significant and sustained increase in hunger, which makes maintaining a caloric surplus easier during bulk phases and can help hard gainers hit required daily intake targets.
  • Strength gains — slower to arrive than with testosterone or oral AAS, but present and linear across a long cycle. Strength peaks later in the cycle, typically at weeks 10–14, as red blood cell mass and muscular development accumulate.
  • Enhanced aerobic capacity — EPO-driven red blood cell elevation improves oxygen delivery to working muscle. This effect makes boldenone uniquely useful for endurance athletes running low-dose cycles compared to most other AAS.

Who It Is For

Boldabol 200 is suited to intermediate users who have completed at least one testosterone-only cycle and understand the basics of AAS management — AI use, bloodwork scheduling, and PCT execution. The 14–20 week cycle requirement makes it a poor fit for users looking for a short, in-and-out cycle.

It is the right choice in these scenarios:

  • Athletes prioritising muscle quality over raw scale weight — boldenone consistently produces leaner, harder-looking gains than testosterone-dominant protocols at comparable weekly doses due to its lower estrogenic burden.
  • Users running a lean bulk or recomposition cycle who want a secondary injectable compound alongside a testosterone base that adds anabolic stimulus without significantly amplifying estrogenic load.
  • Endurance and physique athletes who benefit from the EPO effect — boldenone's red blood cell stimulation improves oxygen utilization and vascularity simultaneously, making it effective across both aesthetic and performance goals.
  • Hard gainers who struggle to sustain high caloric intake — the appetite stimulation boldenone produces is a functional advantage for those who need help hitting bulk diet targets.

Users who should choose something else: those wanting fast results within 8–10 weeks (slow onset makes boldenone inefficient in short cycles — choose Testabol Propionate BD or Mastabol 100 BD instead); users with already-elevated hematocrit or cardiovascular concerns (boldenone's EPO effect raises red blood cell mass more than most other AAS — see bloodwork section).

Boldabol 200 vs Alternatives

Compound Key Differences Choose Boldabol 200 When Choose Alternative When
Boldabol 200 BD
(this product)
200 mg/ml boldenone undecylenate; standard concentration; 1 ml per injection at 400 mg/wk; 5 weeks per vial at 400 mg/wk. First boldenone cycle; standard 400–600 mg/wk protocols; easy per-injection volume management. Running 600–900 mg/wk and want fewer ml per injection — Boldabol Forte is more efficient at higher doses.
Boldabol Forte BD 300 mg/ml boldenone undecylenate; 50% higher concentration; at 600 mg/wk = 2 ml vs 3 ml with Boldabol 200. Experienced boldenone users running 600+ mg/wk who want to reduce weekly injection volume; one vial covers 5 weeks at 600 mg/wk. First boldenone cycle; lower 400 mg/wk dose where the volume saving is marginal.
Decabol 250 BD Nandrolone decanoate 250 mg/ml; more mass and joint lubrication; higher progestogenic activity; requires prolactin monitoring. Heavy bulk cycles; users with joint pain under heavy loads; stacking with testosterone for a classic mass-gaining combination. Lean mass / recomposition goals; users sensitive to prolactin elevation; pre-contest phases.
Trenabol 100 BD Trenbolone base; dramatically higher anabolic potency; no aromatization but significant androgenic and systemic side effects. Advanced mass and hardening cycles; maximum anabolic output required; experienced users managing Tren-specific sides. Intermediate users; first secondary injectable; long comfortable cycles — Tren is significantly harsher than boldenone.

Recommended Combinations

Boldenone should always be run alongside a testosterone base. As an aromatizing compound with moderate androgenic activity, it suppresses the HPG axis fully — a testosterone base is required to maintain physiological function throughout the cycle.

Goal Stack Why It Works
Classic lean bulk Boldabol 200 (400–600 mg/wk) +
Testabol Enanthate BD (400–500 mg/wk)
The go-to boldenone combination. Enanthate's longer half-life pairs naturally with boldenone's 14-day undecylenate ester — both run on a 2×/week schedule. Enanthate adds the estrogenic stimulus for full mass accumulation; boldenone adds lean mass, vascularization, and appetite support. Vial math: 16-week cycle at 400 mg/wk boldenone = 6,400 mg = 3.2 vials (need 4).
Lean mass / recomposition Boldabol 200 (400 mg/wk) +
Testabol Propionate BD (300–400 mg/wk)
Lower estrogenic load combination using propionate's short ester for fine estrogen control. Suitable for athletes running a caloric maintenance or modest surplus where minimum water retention is a priority. Propionate's EOD schedule runs alongside boldenone's 2×/week injections on the same pin days when possible.
Mass + joint support Boldabol 200 (400–600 mg/wk) +
Decabol 250 BD (300–400 mg/wk) +
Testabol Enanthate BD (300–400 mg/wk)
Three-compound bulk stack. Boldenone and nandrolone both contribute lean mass with less estrogenic load than equivalent testosterone doses; nandrolone adds joint lubrication beneficial under heavy lifting loads. Requires monitoring for both E2 and prolactin (nandrolone elevates prolactin).
Pre-contest hardening Boldabol 200 (400 mg/wk, throughout) +
Mastabol 100 BD (400 mg/wk, last 8 wks) +
Stanabol Tablets BD (50 mg/day, last 6 wks)
Boldenone runs the full cycle as the anabolic base. Masteron and Winstrol enter in the final 6–8 weeks to harden the physique, suppress SHBG, and add dense muscle detail. Low combined estrogenic load — AI dose may be reduced or stopped in the final weeks, particularly when Masteron is present.

Side Effects and How to Manage Them

What May Occur Background How to Handle It
Hematocrit elevation (primary concern) Boldenone stimulates erythropoietin (EPO) production more significantly than most other AAS. This drives red blood cell production, raising hematocrit and blood viscosity. At doses of 400–600 mg/week over 14–20 weeks, hematocrit elevation is the most clinically relevant cardiovascular risk of a boldenone cycle — more so than estrogen management. Mandatory CBC monitoring at baseline, week 6, and week 12. If hematocrit exceeds 52%, reduce dose or donate blood. Ecosprin (Aspirin) 75 mg/day throughout the cycle reduces blood viscosity. Do not ignore elevated readings — high hematocrit significantly increases clotting risk.
Mild estrogenic effects Boldenone aromatizes at approximately 50% of testosterone's rate. At 400–600 mg/wk, estrogenic effects are present but typically manageable — less bloat and gynecomastia risk than testosterone-only cycles at comparable doses. Estrogenic load increases when boldenone is stacked with a full testosterone dose. Anastrozole Tablets BD at 0.5 mg EOD or 0.5 mg twice weekly is typically sufficient when boldenone is the primary compound. When stacked with 400+ mg/wk testosterone, standard anastrozole dosing applies. Check E2 at week 4–6 and adjust.
Blood pressure elevation Raised hematocrit and the fluid changes of a long anabolic cycle both contribute to BP elevation. Long 14–20 week cycles carry cumulative cardiovascular load. Ecosprin 75 mg/day from cycle start. Weekly BP monitoring. If systolic exceeds 135 mmHg consistently, add Amlodipine or Telmisartan.
Androgenic effects (acne, hair) Boldenone does not convert meaningfully to DHT, reducing scalp and skin androgenic impact relative to testosterone. Acne and hair thinning are possible but less pronounced than with comparable testosterone doses for most users. For significant acne, Accutane (Isotretinoin) is the most effective intervention. For hair concerns, Minoxidil applied topically.
HDL suppression All AAS suppress HDL. A 16–20 week boldenone cycle represents sustained lipid stress, particularly when stacked with oral compounds. Lipid panel at baseline and week 8. Atorvastatin if HDL drops significantly. Cardio and omega-3 supplementation are standard throughout.
HPG suppression Boldenone fully suppresses LH and FSH. Suppression persists until the undecylenate ester clears — approximately 14–21 days post-cycle. Plan PCT to begin 14–21 days after the last Boldabol 200 injection. See recovery section below.

Bloodwork Monitoring

Lab When to Test Target & Action Threshold
Hematocrit / CBC Baseline; week 6; week 12; end of cycle Hematocrit <52%. The primary monitoring priority for boldenone cycles — EPO stimulation is significant and cumulative over long cycles. If hematocrit reaches 50–52%: reduce dose. Above 52%: pause cycle and donate blood before resuming.
Estradiol (E2) Baseline; week 4–6; every 6 weeks thereafter 20–40 pg/mL on-cycle. Boldenone's lower aromatization rate makes dramatic E2 spikes less common than with testosterone-heavy protocols, but monitoring at week 4–6 confirms AI is appropriately dosed.
Lipid Panel (HDL/LDL) Baseline; week 8 HDL >40 mg/dL. Long boldenone cycles carry sustained lipid suppression pressure. Evaluate at week 8 — if HDL has dropped >30% from baseline, assess need for statin support and reduce any concurrent oral AAS.
Blood Pressure Weekly throughout Target <130/85 mmHg. Monitor consistently — elevated hematocrit and long cycle duration are both BP risk factors with boldenone.
LH + FSH PCT start (day 14–21 post last injection) Will be fully suppressed during cycle. Rising LH and FSH during PCT confirms HPG axis response to SERM therapy.
Total Testosterone (endogenous) 4 weeks into PCT; PCT end Trending toward 300–800 ng/dL. After long 16–20 week boldenone cycles, HPG recovery may take 5–8 weeks of PCT — allow adequate time before considering recovery complete.

Post-Cycle Recovery

The undecylenate ester clears over 14–21 days post-cycle. PCT should begin no earlier than 14 days after the last Boldabol 200 injection to allow meaningful ester clearance before SERM therapy begins. After long cycles (18–20 weeks), waiting the full 21 days is appropriate.

Product Role in PCT
Tamoxifen Tablets BD Primary PCT SERM. Blocks estrogen at the pituitary and hypothalamus, restoring LH and FSH secretion and restarting endogenous testosterone production. Run for 4–6 weeks post-cycle. After long boldenone cycles, 6 weeks is recommended.
Clomiphene Tablets BD Combined with Tamoxifen for the first 3–4 weeks of PCT for enhanced gonadotropin stimulation. Particularly important after cycles of 16 weeks or longer where HPG suppression is deep.
Anastrozole Tablets BD Discontinue at PCT start. Continuing AI use into PCT impairs estrogen's role in HPG feedback and slows LH/FSH recovery. Switch to SERMs only.

For complete PCT protocol guidance, see the PCT guide.

Practical Summary

Key protocol rules for Boldabol 200 British Dragon:

  • Commit to cycle length — boldenone needs 14–20 weeks to deliver its full effect; running it for 8–10 weeks produces suboptimal results given the slow onset. At 400 mg/wk for 16 weeks: 16 × 400 = 6,400 mg = 3.2 vials — budget 4 vials.
  • Inject twice weekly (e.g., Monday and Thursday); at 400 mg/wk this means 1 ml per injection — a comfortable and manageable volume per site.
  • Hematocrit is the primary monitoring priority — schedule a CBC at week 6 and week 12 without exception; boldenone's EPO stimulation is cumulative and can reach action thresholds on long cycles even at moderate doses.
  • AI dose can typically be lower than on a testosterone-only cycle — boldenone's reduced aromatization means 0.5 mg anastrozole twice weekly is often sufficient; confirm at week 4–6 bloodwork before adjusting.
  • Always pair with a testosterone base — boldenone alone causes full HPG suppression without adequate androgenic support; running it without testosterone leads to libido and recovery issues.
  • Begin PCT 14–21 days after the last injection — do not start earlier; the undecylenate ester requires this clearance window before SERM therapy becomes effective.

Boldabol 200 is one of the most consistently used long-cycle injectable compounds available at Steroid Warehouse, valued for the quality of gains it produces relative to the estrogenic load it carries. steroidwarehouse.com stocks British Dragon's complete boldenone lineup — Boldabol 200 alongside the higher-concentration Boldabol Forte 300 mg/ml — giving athletes the option to match concentration to weekly dose requirements. For intermediate users building toward a lean, vascular physique over a structured 16–20 week timeline, Boldabol 200 at 400–600 mg/week paired with a standard testosterone base remains a dependable and well-established protocol.

References

Source Topic Link
New England Journal of Medicine / PubMed Bhasin et al. 1996 — randomized controlled trial using 600 mg/week testosterone enanthate for 10 weeks in healthy men; showed increased fat-free mass, muscle size, and strength, with the largest gains when supraphysiologic testosterone was combined with resistance training Bhasin S, et al. (1996) ↗
NCBI Bookshelf / StatPearls Anabolic steroids overview — clinical reference on synthetic testosterone-derived anabolic-androgenic steroids, androgen receptor activity, medical uses, misuse patterns, oral and injectable AAS forms, monitoring concerns, and adverse effect profile StatPearls: Anabolic Steroids ↗
NCBI Bookshelf / Endotext Androgen physiology and pharmacology — detailed medical overview of testosterone, dihydrotestosterone, androgen receptor signaling, aromatization to estradiol, HPG-axis regulation, synthetic androgen use, and misuse-related endocrine suppression Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗
British Journal of Pharmacology / PubMed Kicman AT 2008 — comprehensive review of the pharmacology of anabolic steroids; covers androgen receptor pharmacology, biotransformation, anabolic and androgenic mechanisms, erythropoietic effects, and pharmacokinetics of multiple AAS including boldenone Kicman AT (2008) ↗
Sports Medicine / PubMed Hartgens F & Kuipers H 2004 — comprehensive review of AAS effects in athletes; covers strength and bodyweight changes, body composition, erythropoiesis, lipid profiles, cardiovascular effects, endocrine suppression, liver effects, and psychological considerations Hartgens F & Kuipers H (2004) ↗
What is Boldabol 200?

Boldabol 200 is an injectable anabolic steroid (Boldenone Undecylenate) for lean muscle growth; see What is Boldabol 200. It's effective—consult professionals for safe use.

How long does Boldabol 200 stay in your system?

Detectable for up to 4-5 months; see How Long Does Boldabol 200 Stay in Your System. Monitor with professional guidance.

What is Boldabol 200 used for in bodybuilding?

It's used for lean muscle growth, strength, and endurance in bulking or cutting; see What is Boldabol 200 Used For in Bodybuilding. It suits intermediate users—use with oversight.

How to take Boldabol 200?

400-800 mg/week for men, 50-100 mg/week for women, split weekly or bi-weekly; see How to Take Boldabol 200. Start low—consult professionals for dosing.

How long does it take to notice effects from Boldabol 200?

Because boldenone undecylenate is a long-acting ester, effects generally develop gradually over several weeks, with steady improvements in performance and physique.

What are the main benefits of Boldabol 200?

Commonly reported benefits include increased lean muscle mass, enhanced strength, improved endurance, better recovery, and support for a quality physique with moderate water retention.

Is Boldabol 200 better for bulking or recomposition?

Boldabol 200 is often associated with lean bulking and recomposition phases due to its reputation for supporting steady muscle gains and athletic performance.

What are the possible side effects of Boldabol 200?

Potential side effects may include acne, oily skin, increased appetite, elevated red blood cell production, and suppression of natural testosterone production.